Keurig Dr Pepper (NASDAQ:KDP – Free Report) had its price objective trimmed by Barclays from $39.00 to $36.00 in a research note issued to investors on Friday morning,Benzinga reports.
Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $36 from $39 and keeps an Overweight rating on the shares as part of a consumer staples Q4 earnings preview. Put simply ...
In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $36.00. The company’s shares closed ...
Keurig Dr Pepper Inc. (NASDAQ:KDP) is a leading non-alcoholic beverage ... On January 17, Lauren Lieberman, analyst at ...
SG Americas Securities LLC lowered its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 40.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The ...
On Jan. 17, Barclays PLC (BCS) reduced its price target for Keurig Dr Pepper to $36 from $39, while maintaining an “Overweight” rating on the stock. The analyst noted, "It feels like there ...
11d
Hosted on MSNAre Wall Street Analysts Bullish on Keurig Dr Pepper Stock?Keurig Dr Pepper Inc. (KDP), with a market cap of $43.5 billion, is a leading beverage company known for its diverse ...
Keurig Dr Pepper Inc. closed 17.55% short of its 52-week high of $38.28, which the company reached on September 24th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results